Miss Jennifer Lane, MEd MA DPhil FRCS(Tr&Orth)

Profile

Jenny studied undergraduate medicine at Exeter College, Oxford and undertook basic medical and surgical training in London. She graduated with distinction from Masters of Surgical Education at Imperial College, London and began training in Academic Orthopaedic surgery as a NIHR Academic Clinical Fellow in Oxford in 2014. 

Jenny undertook her PhD in Musculoskeletal Sciences at the University of Oxford and was funded by Versus Arthritis Clinical Research and MRC Doctoral Training Fellowships for this work. She focussed on the epidemiology of hand conditions which is now quoted in NHS guidelines for patients. 

During the Covid-19 pandemic she was also a core member of an international group of researchers investigating emerging pandemic treatments that changed national policies in Europe and the US. 

She lectures for the Masters in Surgical Science & Practice and DPhil in Musculoskeletal Sciences, University of Oxford, and aims to bring this expertise to east London.

Research

Research Interests:

• Epidemiology
• Real world data
• Big data science
• Hand and wrist surgery
• Trauma and orthopaedic surgery
• Federated network analyses

 

Publications

Key publications

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lane JCE, Weaver J, Kostka K, Duarte-Salles T, et al. (OHDSI Covid-19 collaboration: senior authors Prieto-Alhambra D and Ryan P). Lancet Rheumatology 2020 Nov;2(11):e698-711. PMID:32864627 impact upon EU regulation: https://www.ema.europa.eu/en/news/covid-19-reminder-risk-serious-side-effects-chloroquine-hydroxychloroquine)

Serious postoperative complications and reoperation after carpal tunnel decompression surgery in England: a nationwide cohort analysis. Lane JCE, Craig RS, Rees JL, Gardiner MD, Green J, Prieto-Alhambra D, Furniss D. Lancet Rheumatology 2020 Sep 30;3(1):e49-e57. PMID: 33381769

Serious adverse events and lifetime risk of reoperation after elective shoulder replacement: population based cohort study using hospital episode statistics for England. Craig RS, Lane JCE, Carr AJ, Furniss D, Collins GS, Rees JL. BMJ 2019. Feb 20;364:I298. PMID: 30786996

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. Prats-Uribe A, Sena AG, Lai LYH, Ahmed WU, Alghoul H, Alser O, Alshammari TM, Areia C, Carter W, Casajust P, Dawoud D, Golozar A, Jonnagaddala J, Mehta PP, Gong M, Morales DR, Nyberg F, Posada JD, Recalde M, Roel E, Shah K, Shah NH, Schilling LM, Subbian V, Vizcaya D, Zhang L, Zhang Y, Zhu H, Liu L, Cho J, Lynch KE, Matheny ME, You SC, Rijnbeek PR, Hripcsak G, Lane JCE, Burn E, Reich C, Suchard MA, Duarte-Salles T, Kostka K, Ryan PB, Prieto-Alhambra D. BMJ 2021 May 11;373:n1038. doi: 10.1136/bmj.n1038.PMID: 33975825

Serious adverse event rates and reoperation after arthroscopic shoulder surgery: population based cohort study. JL Rees, R Craig, N Nagra, M Baldwin, JCE Lane, A Price, DJ Beard et al. BMJ 2022;378:e069901

All publications